SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
Attovia Therapeutics, Inc.
@ATTO_InsiderForm 4 Filing: Frazier Life Sciences XI, L.P. Buys $10.0M of $ATTO
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Attovia Therapeutics, Inc.
Ticker: $ATTO
Transaction Value
$10.0M
Price/Share: $1.65
transaction date
2026-08-06
Shares: 6,078,864
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Frazier Life Sciences XI, L.P., holds the title of 10% Owner at Attovia Therapeutics, Inc..
On 2026-08-06, the insider transacted 6,078,864 shares.The shares were transacted at a weighted average price of $1.65 per share, resulting in a total market-relevant value of $10.0M.
Executive Summary Summary
Frazier Life Sciences XI, L.P. (10% Owner) bought $10.0M of $ATTO
Post-Transaction Position: 6,154,213 shares
SEC Accession No: 0001231919-26-000838 (CIK: 1911592)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.